Latest Breaking News On - Sontag innovation the - Page 1 : comparemela.com

/PRNewswire/ MimiVax, Inc., a biotechnology company focused on the development of SurVaxM, a survivin-targeted vaccine therapy for glioblastoma and other.

United statesJohn higginsScott davisMichael ciesielskiNational brain tumor societySontag innovation fundMimivax incSontag foundationBrain tumor investment fundSontag innovation theVaria venturesClinical oncologyManaging directorTech coast angelsNorth americaSontag innovation